Related Experiment Video
Updated: Aug 11, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Bullous pemphigoid in an infant after vaccination]
Carolina Mérida1, Jorge A Martínez-Escribano, José F Frías
1Sección de Alergología, Hospital Universitario Virgen de la Arrixaca, Ctra. Madrid-Cartagena, 30120 El Palmar, Murcia, Spain. jmescribano@huva.es
Insights
Bullous pemphigoid (BP) in infants is rare. This case study details a two-month-old infant who developed BP lesions after vaccinations, which resolved with treatment.
Area of Science:
- Pediatric Dermatology
- Immunology
Background:
- Bullous pemphigoid (BP) typically affects the elderly.
- Infantile BP is uncommon, with limited case reports.
Observation:
- A two-month-old infant presented with bullous lesions on palms and soles.
- Lesions appeared after the first dose of hepatitis B, polio, DTP, and HiB vaccines.
- A second, more generalized outbreak occurred after the second vaccine dose.
Findings:
- The infant's BP resolved with topical and systemic corticosteroid treatment (deflazacort).
- The patient remained lesion-free for five years post-vaccination and subsequent treatment.
- No recurrence of BP was observed despite completion of the standard vaccination schedule.
Implications:
- This case suggests a potential, though rare, association between certain childhood vaccinations and the onset of bullous pemphigoid.
- Early diagnosis and appropriate treatment are crucial for managing infantile BP.
- Further research may be warranted to explore the immunological mechanisms linking vaccines and BP in infants.
Abstract:
Bullous pemphigoid (BP) is a disease that characteristically affects the elderly, although cases have been described in children. We present a case of BP in a two-month-old infant with bullous lesions on the palms and soles, which appeared one week after receiving the first dose of the hepatitis B, polio, DTP and HiB vaccine. She was treated with sulphated water, dexamethasone and fusidic acid, and the lesions disappeared. One month later, she presented with a new, more generalized outbreak, three days after the second dose of the same vaccine. The skin eruption completely subsided 3 months after treatment with deflazacort was initiated (1 mg/kg/day). After five years of follow up, the patient has not presented with lesions again, despite having received the rest of the vaccines on the official schedule.
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Chickenpox
Smallpox
Vaccinations
Poliomyelitis
Diphtheria

